Physiologic Indicators for Prognosis in Abdominal Sepsis Study
NCT ID: NCT03408600
Last Updated: 2018-09-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
4000 participants
OBSERVATIONAL
2018-02-01
2018-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Physiological deterioration often precedes clinical deterioration as patients develop critical illness. In this study, the investigators aim to evaluate vital signs in a global cohort of patients with acute secondary peritonitis, determining which parameters are statistically significant to predict in-hospital mortality and ICU admission.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Derivation and Validation of a Prognostic Model for Septic Patients at Hospital Admission
NCT03601767
Prognostic Value of Proadrenomedullin in Intra-abdominal Sepsis
NCT03061500
Shock Indices Use for Early Mortality From Septic Shock
NCT05088109
Endotoxin in Gram-negative Septic Shock
NCT01602354
Effect of Immunophenotype on Prognosis of Sepsis
NCT05602584
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study will not attempt to change or modify the clinical practice of the participating physicians: neither informed consent or formal approval by local Ethics Committee will be required because of the purely observational nature of the study.
The study will be monitored by the principal investigator, which will investigate and verify missing or unclear data submitted to a central database.
The study protocol has been approved by the board of the WSES and the study will be conducted under its supervision. The board of the WSES grants the proper ethical conduct of the study.
The data collection will be anonymous, as well as the name of the patients or hospital will be not collected in the website. Every hospital will continue following their ethical standards and local rules. The list of the submitted cases will not be recognized by investigators and linked to the submitting hospital. Individual researchers will take personal responsibility of data collection of this study.
In each center, the coordinator will collect and fill the data in an online case report system. These data included the following:
* Patient and disease characteristics
* Diagnostic profiles
* Treatment profiles
* Post-operative course
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Management
To evaluate vital signs in a global cohort of patients with acute peritonitis, determining which parameters are statistically significant to predict in-hospital mortality and ICU admission.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
World Society of Emergency Surgery
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Massimo Sartelli
Director
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
WSES
Bologna, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WSES/4
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.